메뉴 건너뛰기




Volumn 8, Issue 2, 2014, Pages 258-265

Drug susceptibility surveillance of influenza viruses circulating in the United States in 2011-2012: Application of the WHO antiviral working group criteria

Author keywords

Influenza; Neuraminidase inhibition; Oseltamivir; Zanamivir

Indexed keywords

INFLUENZA; NEURAMINIDASE INHIBITION; OSELTAMIVIR; ZANAMIVIR;

EID: 84894482337     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/irv.12215     Document Type: Article
Times cited : (39)

References (35)
  • 1
    • 78650978283 scopus 로고    scopus 로고
    • Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro
    • Gubareva LV, Trujillo AA, Okomo-Adhiambo M et al. Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro. Antivir Ther 2010; 15:1151-1159.
    • (2010) Antivir Ther , vol.15 , pp. 1151-1159
    • Gubareva, L.V.1    Trujillo, A.A.2    Okomo-Adhiambo, M.3
  • 3
    • 84455192539 scopus 로고    scopus 로고
    • Efficacy, safety, and pharmacokinetics of intravenous peramivir in children with 2009 pandemic H1N1 influenza A virus infection
    • Sugaya N, Kohno S, Ishibashi T et al. Efficacy, safety, and pharmacokinetics of intravenous peramivir in children with 2009 pandemic H1N1 influenza A virus infection. Antimicrob Agents Chemother 2012; 56:369-377.
    • (2012) Antimicrob Agents Chemother , vol.56 , pp. 369-377
    • Sugaya, N.1    Kohno, S.2    Ishibashi, T.3
  • 4
    • 62349105166 scopus 로고    scopus 로고
    • Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08
    • Hauge SH, Dudman S, Borgen K et al. Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08. Emerg Infect Dis 2009; 15:155-162.
    • (2009) Emerg Infect Dis , vol.15 , pp. 155-162
    • Hauge, S.H.1    Dudman, S.2    Borgen, K.3
  • 5
    • 40549111528 scopus 로고    scopus 로고
    • Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe
    • pii:.
    • Lackenby A, Hungnes O, Dudman SG et al. Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe. Euro Surveill 2008; 13:pii:8026.
    • (2008) Euro Surveill , vol.13 , pp. 8026
    • Lackenby, A.1    Hungnes, O.2    Dudman, S.G.3
  • 6
    • 64749089192 scopus 로고    scopus 로고
    • Update: influenza activity-United States, September 28, 2008-April 4and composition of the 2009-10 influenza vaccine
    • CDC
    • CDC. Update: influenza activity-United States, September 28, 2008-April 4and composition of the 2009-10 influenza vaccine. Morb Mortal Wkly Rep 2009; 58:369-374.
    • (2009) Morb Mortal Wkly Rep , vol.58 , pp. 369-374
  • 7
    • 72049131299 scopus 로고    scopus 로고
    • Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season
    • Baranovich T, Saito R, Suzuki Y et al. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season. J Clin Virol 2010; 47:23-28.
    • (2010) J Clin Virol , vol.47 , pp. 23-28
    • Baranovich, T.1    Saito, R.2    Suzuki, Y.3
  • 8
    • 65349131787 scopus 로고    scopus 로고
    • Update: infections with a swine-origin influenza A (H1N1) virus-United States and other countries, April 28, 2009
    • CDC
    • CDC. Update: infections with a swine-origin influenza A (H1N1) virus-United States and other countries, April 28, 2009. Morb Mortal Wkly Rep 2009; 58:431-433.
    • (2009) Morb Mortal Wkly Rep , vol.58 , pp. 431-433
  • 9
    • 79551650598 scopus 로고    scopus 로고
    • Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States
    • Graitcer SB, Gubareva L, Kamimoto L et al. Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States. Emerg Infect Dis 2011; 17:255-257.
    • (2011) Emerg Infect Dis , vol.17 , pp. 255-257
    • Graitcer, S.B.1    Gubareva, L.2    Kamimoto, L.3
  • 10
    • 84856325057 scopus 로고    scopus 로고
    • Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11
    • Storms AD, Gubareva LV, Su S et al. Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11. Emerg Infect Dis 2012; 18:308-311.
    • (2012) Emerg Infect Dis , vol.18 , pp. 308-311
    • Storms, A.D.1    Gubareva, L.V.2    Su, S.3
  • 11
    • 79951568635 scopus 로고    scopus 로고
    • Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010/11
    • Lackenby A, Moran GJ, Pebody R et al. Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010/11. Euro Surveill 2011; 16:19784.
    • (2011) Euro Surveill , vol.16 , pp. 19784
    • Lackenby, A.1    Moran, G.J.2    Pebody, R.3
  • 12
    • 80052842317 scopus 로고    scopus 로고
    • Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010
    • Meijer A, Jonges M, Abbink F et al. Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010. Antiviral Res 2011; 92:1-89.
    • (2011) Antiviral Res , vol.92 , pp. 1-89
    • Meijer, A.1    Jonges, M.2    Abbink, F.3
  • 13
    • 79952319815 scopus 로고    scopus 로고
    • Monitoring and characterization of oseltamivir-resistant pandemic (H1N1) 2009 virus, Japan, 2009-2010
    • Ujike M, Ejima M, Anraku A et al. Monitoring and characterization of oseltamivir-resistant pandemic (H1N1) 2009 virus, Japan, 2009-2010. Emerg Infect Dis 2011; 17:470-479.
    • (2011) Emerg Infect Dis , vol.17 , pp. 470-479
    • Ujike, M.1    Ejima, M.2    Anraku, A.3
  • 14
    • 84855400938 scopus 로고    scopus 로고
    • Community transmission of oseltamivir-resistant A(H1N1)pdm09 influenza
    • Hurt AC, Hardie K, Wilson NJ et al. Community transmission of oseltamivir-resistant A(H1N1)pdm09 influenza. N Engl J Med 2011; 365:2541-2542.
    • (2011) N Engl J Med , vol.365 , pp. 2541-2542
    • Hurt, A.C.1    Hardie, K.2    Wilson, N.J.3
  • 15
    • 84862902952 scopus 로고    scopus 로고
    • Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia
    • Hurt AC, Hardie K, Wilson NJ et al. Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia. J Infect Dis 2012; 206:148-157.
    • (2012) J Infect Dis , vol.206 , pp. 148-157
    • Hurt, A.C.1    Hardie, K.2    Wilson, N.J.3
  • 16
    • 84864557850 scopus 로고    scopus 로고
    • The fluorescence neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors
    • Hurt AC, Okomo-Adhiambo M, Gubareva LV. The fluorescence neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors. Methods Mol Biol 2012; 865:115-125.
    • (2012) Methods Mol Biol , vol.865 , pp. 115-125
    • Hurt, A.C.1    Okomo-Adhiambo, M.2    Gubareva, L.V.3
  • 17
    • 84864536567 scopus 로고    scopus 로고
    • The chemiluminescent neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors
    • Okomo-Adhiambo M, Hurt AC, Gubareva LV. The chemiluminescent neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors. Methods Mol Biol 2012; 865:95-113.
    • (2012) Methods Mol Biol , vol.865 , pp. 95-113
    • Okomo-Adhiambo, M.1    Hurt, A.C.2    Gubareva, L.V.3
  • 18
    • 0033961667 scopus 로고    scopus 로고
    • Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors
    • Tisdale M. Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors. Rev Med Virol 2000; 10:45-55.
    • (2000) Rev Med Virol , vol.10 , pp. 45-55
    • Tisdale, M.1
  • 19
    • 12244295453 scopus 로고    scopus 로고
    • Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network
    • Wetherall NT, Trivedi T, Zeller J et al. Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network. J Clin Microbiol 2003; 41:742-750.
    • (2003) J Clin Microbiol , vol.41 , pp. 742-750
    • Wetherall, N.T.1    Trivedi, T.2    Zeller, J.3
  • 20
    • 0037636478 scopus 로고    scopus 로고
    • Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir
    • McKimm-Breschkin J, Trivedi T, Hampson A et al. Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob Agents Chemother 2003; 47:2264-2272.
    • (2003) Antimicrob Agents Chemother , vol.47 , pp. 2264-2272
    • McKimm-Breschkin, J.1    Trivedi, T.2    Hampson, A.3
  • 21
    • 77956116079 scopus 로고    scopus 로고
    • Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays
    • Nguyen HT, Sheu TG, Mishin VP et al. Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays. Antimicrob Agents Chemother 2010; 54:3671-3677.
    • (2010) Antimicrob Agents Chemother , vol.54 , pp. 3671-3677
    • Nguyen, H.T.1    Sheu, T.G.2    Mishin, V.P.3
  • 22
    • 84867469314 scopus 로고    scopus 로고
    • Meetings of the WHO working group on surveillance of influenza antiviral susceptibility - Geneva and June 2012
    • WHO
    • WHO. Meetings of the WHO working group on surveillance of influenza antiviral susceptibility - Geneva and June 2012. Wkly Epidemiol Rec 2012; 87:369-374.
    • (2012) Wkly Epidemiol Rec , vol.87 , pp. 369-374
  • 23
    • 84882611877 scopus 로고    scopus 로고
    • Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season
    • Okomo-Adhiambo M, Sleeman K, Lysen C et al. Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season. Influenza Other Respi Viruses 2013; 7:645-658.
    • (2013) Influenza Other Respi Viruses , vol.7 , pp. 645-658
    • Okomo-Adhiambo, M.1    Sleeman, K.2    Lysen, C.3
  • 24
    • 79952163859 scopus 로고    scopus 로고
    • Neuraminidase inhibitor susceptibility testing in human influenza viruses: a laboratory surveillance perspective
    • Okomo-Adhiambo M, Sleeman K, Ballenger K et al. Neuraminidase inhibitor susceptibility testing in human influenza viruses: a laboratory surveillance perspective. Viruses 2010; 2:2269-2289.
    • (2010) Viruses , vol.2 , pp. 2269-2289
    • Okomo-Adhiambo, M.1    Sleeman, K.2    Ballenger, K.3
  • 25
    • 67650410050 scopus 로고    scopus 로고
    • Influenza genome analysis using pyrosequencing method: current applications for a moving target
    • Deyde VM, Gubareva LV. Influenza genome analysis using pyrosequencing method: current applications for a moving target. Expert Rev Mol Diagn 2009; 9:493-509.
    • (2009) Expert Rev Mol Diagn , vol.9 , pp. 493-509
    • Deyde, V.M.1    Gubareva, L.V.2
  • 26
    • 50949106863 scopus 로고    scopus 로고
    • Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008
    • Sheu TG, Deyde VM, Okomo-Adhiambo M et al. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob Agents Chemother 2008; 52:3284-3292.
    • (2008) Antimicrob Agents Chemother , vol.52 , pp. 3284-3292
    • Sheu, T.G.1    Deyde, V.M.2    Okomo-Adhiambo, M.3
  • 27
    • 84894452113 scopus 로고    scopus 로고
    • ISIRV-AVG. Available atAccessed 19 July 2013
    • ISIRV-AVG. Available at http://www.isirv.org/site/index.php/special-interest-groups/antiviral-group-home (Accessed 19 July 2013).
  • 28
    • 72049099839 scopus 로고    scopus 로고
    • Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007
    • Tashiro M, McKimm-Breschkin JL, Saito T et al. Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007. Antivir Ther 2009; 14:751-761.
    • (2009) Antivir Ther , vol.14 , pp. 751-761
    • Tashiro, M.1    McKimm-Breschkin, J.L.2    Saito, T.3
  • 29
    • 1542509356 scopus 로고    scopus 로고
    • Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir
    • Hurt AC, Barr IG, Hartel G et al. Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir. Antiviral Res 2004; 62:37-45.
    • (2004) Antiviral Res , vol.62 , pp. 37-45
    • Hurt, A.C.1    Barr, I.G.2    Hartel, G.3
  • 30
    • 33745635392 scopus 로고    scopus 로고
    • Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use
    • Monto AS, McKimm-Breschkin JL, Macken C et al. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother 2006; 50:2395-2402.
    • (2006) Antimicrob Agents Chemother , vol.50 , pp. 2395-2402
    • Monto, A.S.1    McKimm-Breschkin, J.L.2    Macken, C.3
  • 31
    • 84894414075 scopus 로고    scopus 로고
    • CDC. Available at:Accessed 19 July 2013
    • CDC. Available at: http://www.cdc.gov/flu/weekly/ (Accessed 19 July 2013).
  • 32
    • 84860334106 scopus 로고    scopus 로고
    • Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods
    • Nguyen HT, Fry AM, Gubareva LV. Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods. Antivir Ther 2012; 17:159-173.
    • (2012) Antivir Ther , vol.17 , pp. 159-173
    • Nguyen, H.T.1    Fry, A.M.2    Gubareva, L.V.3
  • 33
    • 84894505423 scopus 로고    scopus 로고
    • WHO. Available at:Accessed 19 July 2013
    • WHO. Available at: http://www.who.int/influenza/gisrs_laboratory/flunet/en/ (Accessed 19 July 2013).
  • 34
    • 74849119655 scopus 로고    scopus 로고
    • Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses
    • Okomo-Adhiambo M, Nguyen HT, Sleeman K et al. Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses. Antiviral Res 2010; 85:381-388.
    • (2010) Antiviral Res , vol.85 , pp. 381-388
    • Okomo-Adhiambo, M.1    Nguyen, H.T.2    Sleeman, K.3
  • 35
    • 84894422955 scopus 로고    scopus 로고
    • CDC. Available at:Accessed 19 July 2013
    • CDC. Available at: http://www.cdc.gov/flu/avianflu/h5n1-genetic-changes.htm (Accessed 19 July 2013).


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.